Your browser doesn't support javascript.
loading
Predictors of outcomes after PCI with incomplete revascularization: Impact of CTO and LAD vessel.
Kuno, Toshiki; Weisz, Giora; Généreux, Philippe; Claessen, Bimmer E; Shechter, Michael; Alexander, Karen P; James, Stefan K; Ohman, E Magnus; Dressler, Ovidiu; Mehran, Roxana; Ben-Yehuda, Ori; Stone, Gregg W.
Afiliação
  • Kuno T; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Weisz G; Department of Medicine, Mount Sinai Beth Israel Hospital, New York, New York, USA.
  • Généreux P; Division of Cardiology, Montefiore Medical Center, Bronx, New York, USA.
  • Claessen BE; Division of Cardiology, Columbia University Medical Center, NewYork Presbyterian Hospital, New York, New York, USA.
  • Shechter M; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Alexander KP; Department of Cardiology, Heart Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • James SK; The Leviev Cardiothoracic & Vascular Center, Sheba Medical Center, Tel Hashomer, Israel.
  • Ohman EM; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Dressler O; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Mehran R; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Ben-Yehuda O; Cardiovascular Research Foundation, New York, New York, USA.
  • Stone GW; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Article em En | MEDLINE | ID: mdl-39007455
ABSTRACT

BACKGROUND:

Incomplete revascularization (ICR) after percutaneous coronary intervention (PCI) is associated with mortality and morbidity.

AIM:

We sought to investigate whether ICR in the left anterior descending artery (LAD) is worse than ICR of the right coronary artery (RCA) or left circumflex artery (LCX); and whether ICR in patients with a chronic total occlusion (CTO) is worse than in those without.

METHODS:

In the RIVER-PCI trial, 2651 patients with ICR after PCI were randomly assigned to ranolazine or placebo. Angiograms were assessed at an independent core laboratory in 2501 patients (94.3%). The primary endpoint was the composite of ischemia-driven revascularization or hospitalization.

RESULTS:

A total of 1664 patients (66.5%) had ICR involving the LAD, whereas 837 (33.5%) had ICR limited to the RCA or LCX. At median follow-up of 643 days, the primary endpoint occurred in 26.9% versus 26.5% of patients (adjusted HR [aHR] 1.03, 95% confidence interval [CI] 0.88-1.21). A nonrecanalized CTO was present in 854 patients (34.1%) with ICR after PCI. The primary endpoint occurred in 28.6% versus 25.9% of ICR patients with versus without a CTO (aHR 1.10, 95% CI 0.94-1.29). However, patients with a CTO had higher rates of ischemia-driven hospitalization without revascularization (aHR 1.27, 95% CI 1.04-1.56), heart failure hospitalization (aHR 2.69, 95% CI 1.61-4.59) and myocardial infarction (aHR 1.46, 95% CI 1.11-1.92) compared with those without.

CONCLUSIONS:

The 2-year prognosis was similar in post-PCI patients with ICR whether the LAD was versus was not involved. ICR patients with a CTO had more frequent hospitalizations for ischemia and myocardial infarctions compared with those without.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article